baber/WOPTO huggingface dataset:
Patent JP-3164856-B2 (JP)
IPC: C08K5/29
Filed: 1991-10-23
Granted: 2001-05-14
Abstract: Concentrate of a flame retardant additive, in the form of nonextruded particles, each one comprising:   A) a matrix of a nonextruded, as polymerized particle, preferably spheroidal, of a polymer or copolymer of olefins having porosity greater than or equal to 15%, expressed as a percent of the void volume on the total volume of the particle, B) the product of reaction between bismuth or antimony trichloride or tribromide, or their mixtures, and one or more amines; wherein said product (B) is made "in situ" and deposited on the surface of the matrix and inside the pores thereof. d
Patent JP-2958352-B2 (JP)
IPC: A01D67/00
Filed: 1990-11-26
Granted: 1999-10-06
Abstract: A mower includes a frame having a connecting mechanism for connecting the frame to a motor vehicle. The mower also includes at least one harvesting mechanism which comprises cutting elements and is connected to the frame through a suspension device. The suspension device permits the displacement in height of the harvesting mechanism relative to the frame. The mower further includes a lightening device operatively connected to the harvesting mechanism and comprising at least one spring connected directly to the harvesting mechanism. The lightening device makes it possible to reduce the pressure with which the harvesting mechanism rests on the ground by transferring a part of the weight of the harvesting mechanism to the frame.
Patent JP-2935517-B2 (JP)
IPC: C08F2/00
Filed: 1989-12-27
Granted: 1999-08-16
Abstract: The copolymers comprise from 96 to 99.6 mol% of ethylene and from 0.4 to 4 mol% of a C3-C6-alkenecarboxylic acid or an ester of this acid having a total of up to 14 carbon atoms, or mixtures of these monomers, and are obtainable by polymerisation in a continuous tubular reactor at a pressure of from 500 to 5000 bar and at elevated temperature in the presence of initiators which decompose to form free radicals, by adding a mixture of said reaction components only at the inlet point of the tubular reactor, the temperature in a first reaction zone being limited to about 240 DEG C, further initiator being metered in at the beginning of a second reaction zone after the temperature has been reduced by from 5 to 20 DEG C, and the reaction being completed at temperatures of up to 300 DEG C.
Patent JP-3165206-B2 (JP)
IPC: A61B17/115
Filed: 1991-11-29
Granted: 2001-05-14
Abstract: The present invention relates to an improved surgical stapler (20) that prevents refiring of a spent staple cartridge (60). More specifically, this invention includes a simple, inexpensive mechanical locking mechanism which prevents refiring of a spent staple cartridge (60) by blocking the path of the firing and/or cutting means of the stapler (20). <IMAGE>
Patent JP-H0724669-B2 (JP)
IPC: A61F5/56
Filed: 1991-11-27
Abstract: PCT No. PCT/HU91/00049 Sec. 371 Date May 27, 1993 Sec. 102(e) Date May 27, 1993 PCT Filed Nov. 27, 1991 PCT Pub. No. WO92/09249 PCT Pub. Date Jun. 11, 1992A device is provided to prevent or reduce night clenching and grinding of teeth, as well as to impede snoring. The device is adapted to be placed into a mouth cavity of a patient and includes a conchiform element which is provided with an outer surface adapted to fit into the mouth cavity at an essentially closed position of upper and lower rows of the teeth. The conchiform element is also provided with an inner surface adapted to enclose a tip of a tongue of the patient entirely within the mouth cavity. An extension is adapted to be located under the tongue and has a notched indentation for receiving a ligament of the patient. A retaining element is fixed to the outer surface through a coupling member of a size sufficiently large enough to prevent sucking by the patient.
Patent JP-2648303-B2 (JP)
IPC: G01N33/53
Filed: 1986-03-28
Granted: 1997-08-27
Abstract: The polynucleotide sequence fragment conferring immunologic specificity to papillomavirus (PV) has been located and isolated. From this information, assays for type-specific PV, including DNA probes, RNA probes, immunoassays and the like are produced. The vaccines against specific PVs may be produced also. Further, the genus-specific amino acid sequence of the L1 capsid protein has been identified.
Patent JP-H0347253-B2 (JP)
IPC: A61K39/102
Filed: 1983-07-01
Abstract: A water-soluble covalent polysaccharide-exotoxoid conjugate having a molecular size between 140,000 and 4,500,000 dalton and a ribose/protein ratio between 0.25 and 1.00, capable of producing T-cell dependent antibody response to polysaccharide from H. influenzae b, is prepared by mixing a derivatized diphtheria or tetanus toxoid in a substantially cyanogen halide-free solution with a cyanogen halide-activated capsular H. influenzae b polysaccharide hapten consisting of approximately equimolar amounts of ribose, ribitol and phosphate, which polysaccharide had previously been heat sized until more than 60% attained a molecular size between 200,000 and 2,000,000 dalton.
Patent JP-2509269-B2 (JP)
IPC: G08G1/09
Filed: 1987-04-14
Granted: 1996-06-19
Abstract: PCT No. PCT/FR87/00123 Sec. 371 Date Dec. 7, 1987 Sec. 102(e) Date Dec. 7, 1987 PCT Filed Apr. 14, 1987 PCT Pub. No. WO87/06381 PCT Pub. Date Oct. 22, 1987.Road safety installation with emission of sound messages for every type of signalling panel fixed along a road, including a fixed emitter device emitting a coded infrared radiation signal corresponding to the type of signalling panel to which it is associated for every signalling panel along a road and on every vehicle circulating along the road, a receiver device receiving the coded infrared radiation signal (i) delivered by the fixed emitter device on every vehicle and converting the signal into a clear sound message emitted for the attention of the driver of the vehicle; the emitter device feeds an infrared radiation emitter via an encoder, so that the fixed emitter device delivers, in the direction of the vehicles arriving on the road, the coded infrared signal, and a second sensor controlling a normally open switch which is closed in order to start the emitter device in operation, when the sound sensor perceives the noise emitted by the vehicle, and the receiver device comprises an infrared radiation sensor which is mounted on the vehicle, the sensor being connected by a filtering circuit to a decoder of which the output is connected to a selector of the appropriate sound message.
Patent JP-4359651-B2 (JP)
IPC: A61K31/704
Filed: 1997-06-24
Granted: 2009-11-04
Abstract: The invention relates to the use of certain chelating agents and their metal chelates and to the use of certain manganese containing compounds, in particular manganese chelates, in the manufacture of a therapeutic agent for use in reducing the cardiotoxicity of an antitumor agent. Such compounds are particularly effective in reducing the side-effects of anthracycline drugs and/or paclitaxel.
Patent JP-H0689436-B2 (JP)
IPC: C22C38/52
Filed: 1991-02-05
Abstract: A high strength, high fracture toughness steel alloy consisting essentially of, in weight percent, about C 0.2-0.33, Mn 0.20 max., Si 0.1 max., P 0.008 max., S 0.004 max., Cr 2-4, Ni 10.5-15, Mo 0.75-1.75, Co 8-17, Ce effective amount-0.030, La effective amount-0.01, Fe balance, and an article made therefrom are disclosed. A small but effective amount of calcium can be present in this alloy in substitution for some or all of the cerium and lanthanum. The alloy is an age-hardenable martensitic steel alloy which provides a unique combination of tensile strength and fracture toughness. The alloy provides excellent mechanical properties when hardened by vaccum heat treatment with inert gas cooling and has a low ductile-to-brittle transition temperature.
Patent JP-4024313-B2 (JP)
IPC: C12N15/09
Filed: 1998-07-03
Granted: 2007-12-19
Abstract: Disclosed is a substantially pure MAPK (mitogen-activated protein kinase) kinase derived from a vertebrate, which is activated by a stimulus induced by TNF- alpha and/or by a stimulation of Fas antigen, and which in turn activates SAPK/JNK, but does not activate p38; and also disclosed is a DNA coding for the same. By the use of the novel MAPK kinase and the DNA coding for the same of the present invention, it has become possible to screen a novel substance having the capability to treat or prevent diseases resulting from an excess activation or inhibition of a MAP kinase cascade, and also to provide a diagnostic reagent for such diseases. In addition, the DNA of the present invention encoding the MAPK kinase can be used as a gene source for gene therapy. Further disclosed are a replicable recombinant DNA which comprises a replicable expression vector and, operably inserted therein, the above-mentioned DNA; a cell of a microorganism or cell culture, which is transformed with the above-mentioned replicable recombinant DNA; a polypeptide of a dominant negative form of the above-mentioned MAPK kinase and a DNA coding for the same; and an antibody capable of binding specifically to the above-mentioned MAPK kinase. <IMAGE>
Patent JP-H0833882-B2 (JP)
IPC: G06F17/15
Filed: 1987-11-26
Abstract: PCT No. PCT/GB87/00845 Sec. 371 Date May 16, 1989 Sec. 102(e) Date May 16, 1989 PCT Filed Nov. 26, 1987 PCT Pub. No. WO88/04079 PCT Pub. Date Jun. 2, 1988.A digital cross and auto correlator or structurator receives a stream of pulses of varying time separation forming an input signal. A plurality of channels each receives this input signal which is sampled to provide a series of digital numbers in successive sample time intervals. Each channel has a delay for delaying an input signal to a delay value to provide a delayed signal, and an arithmetic section for receiving at one input a non-delayed input signal and at another input the delayed signal. An accumulator receives the output of the arithmetic section. The collective output of the channels provides the required auto or cross correlation function. The correlator has means in each channel for providing a sample time interval and a delay value that are independent of one another and of other channels. The sample time and delay value are set by the frequency of and phase difference respectively between clock pulses.
Patent JP-3199731-B2 (JP)
IPC: A61B5/021
Filed: 1991-07-19
Granted: 2001-08-20
Abstract: PCT No. PCT/EP91/01358 Sec. 371 Date Feb. 18, 1993 Sec. 102(e) Date Feb. 18, 1993 PCT Filed Jul. 19, 1991 PCT Pub. No. WO92/03087 PCT Pub. Date Mar. 5, 1992.The blood pressure measuring device (10) has a bowl-shaped casing (11) in which is arranged a pressure measuring system with a measuring scale (13) and indicator. The casing (11) is closed at its upper edge by a transparent cover plate (25). This primary casing (11) is surrounded at a given distance on the outside by a protective housing (15), whereby the base (18) of the protective housing (15) is combined in one piece with the base (16) of the primary casing (11). The compressed air line is connected either through a hole (22) in the base (16) of the casing (11) or through the casing walls. In the latter case, there is a material bridge in the space between the wall of the primary casing (11) and of the protective housing (15).
Patent JP-3176928-B2 (JP)
IPC: H01P7/10
Filed: 1995-10-04
Granted: 2001-06-18
Abstract: PCT No. PCT/FI95/00544 Sec. 371 Date Jun. 4, 1996 Sec. 102(e) Date Jun. 4, 1996 PCT Filed Oct. 4, 1995 PCT Pub. No. WO96/11508 PCT Pub. Date Apr. 18, 1996A dielectric resonator including a dielectric cylindrical resonator disc, and a resonance frequency controller. The frequency controller includes a dielectric cylindrical adjustment disc provided on the resonator disc so that the adjustment disc is movable in the radial direction for controlling the resonance frequency of the resonator. The frequency controller further includes a dielectric fine adjustment disc, provided on the adjustment disc so that the fine adjustment disc is movable by a movement of an adjustment mechanism with respect to the adjustment disc for fine adjustment of the resonance frequency. Thus, the frequency controller has two slopes of adjustment, whereby the adjustment is fast due to the movement of both adjustment discs, and also extremely accurate due to the fine adjustment function, which is achieved when the thinner adjustment disc alone is moved.
Patent JP-2755828-B2 (JP)
IPC: G06F21/62
Filed: 1995-01-13
Granted: 1998-05-25
Abstract: An application memory card system includes a secure memory card which can be operatively connected to communicate with a host mainframe microprocessor or hand held device host microprocessor via a standard interface. The secure memory card contains an application processor and an access control microprocessor (ACP), each of which connect through an internal bus to a number of non-volatile addressable memory chips, each organized into a plurality of blocks. Each microprocessor has an additional control signal line included in a control bus portion of its bus for specifying "Execute" access. An access discrimination logic unit which connects to the internal bus and to the non-volatile memory includes an access by type memory writable by the application processor under the control of the ACP for maintaining security. The access discrimination logic unit combines the "Execute" control access signal from a microprocessor with a signal designating the microprocessor source (e.g. external or internal) to define the type of memory access requested and transfers a control enabling signal as a function of the state of the selected stored access control bit indicating if the requested access is allowed to the addressed block.
Patent JP-3519740-B2 (JP)
IPC: B01J32/00
Filed: 1995-11-20
Granted: 2004-04-19
Abstract: PCT No. PCT/FR95/01524 Sec. 371 Date Nov. 19, 1997 Sec. 102(e) Date Nov. 19, 1997 PCT Filed Nov. 20, 1995 PCT Pub. No. WO97/19019 PCT Pub. Date May 29, 1997A process for catalytically oxidizing the H2S present at low concentration in a gas to sulphur wherein the gas together with a gas containing free oxygen in a quantity to provide and O2 to H2S mole ratio ranging from 0.05 to 10 are contacted with a catalyst for selectively oxidizing H2S to sulphur, the catalyst comprising a support based on silicon carbide associated with a catalytic active phase containing at least one transition metal such as Fe, Ni, Cr, Co, Cu, Ag, Mn, Mo, Ti, W or V, in a form of a metal compound and/or in the elemental state. Prior to treating the gas, the oxidation catalyst is subjected to an activation treatment which loads the active phase of the catalyst to provide maximum sulphurization of the metal of the catalyst. In an alternate embodiment, the oxidation of the H2S is performed below the dew point of the sulphur. In another embodiment, the oxidation is performed at a temperature above the dew point of sulphur and in particular between 200 DEG  C. and 500 DEG  C. Also disclosed is a catalyst for selectively oxidizing H2S to sulphur which comprises a catalytically active phase based on at least one transition metal such as indicated above in combination with a silicon carbide support.
Patent JP-3345014-B2 (JP)
IPC: C08G18/00
Filed: 1994-03-04
Granted: 2002-11-18
Abstract: Process for the preparation of a rigid polyurethane or urethane-modified polyisocyanurate foam in the presence of a blowing agent mixture comprising cyclopentane and a certain amounts of other organic compounds as co-blowing agenrts, the the saturated vapour pressure of said co-blowing agents in bar at Tuse (v.p.) complying with the following equation (I)     <IMAGE>  (I)  wherein C is the mole % of said co-blowing agent in gaseous form on the total blowing agent mixture in the gaseous phase after foaming and Tuse is the temperature in  DEG K. at which the foam is used.
Patent JP-3869017-B2 (JP)
IPC: F17C1/04
Filed: 1997-12-12
Granted: 2007-01-17
Abstract: The tank is made up of a plurality of elementary tanks such as tubes (20) connected in parallel to at least one manifold device (30, 32), and it includes closure valves enabling any one of the elementary tanks to be isolated in response to a drop in the pressure contained therein.
Patent JP-3904241-B2 (JP)
IPC: A61B18/00
Filed: 1997-12-19
Granted: 2007-04-11
Abstract: A catheter for the treatment of tumors by hyperthermia induced by radiofrequency or other energy comprises a tubular body (1) having a proximal end (2) connected to a handle member and near the other end a cooled metal plate (5) capable to act as active electrode provided with an electric cable (8) for the connection to the energy generator and with thermistors (9, 10) to be connected to the display of the said generator, the tubular body (1) having at least a longitudinal channel (11, 12) for the passage of tissual thermistors, a longitudinal channel for the passage of electric cables and a pair of longitudinal channels for inflow and outflow pipes of the liquid cooling the metal plate (5).
Patent JP-3741730-B2 (JP)
IPC: A61M5/50
Filed: 1996-04-02
Granted: 2006-02-01
Abstract: PCT No. PCT/CH96/00116 Sec. 371 Date Feb. 26, 1998 Sec. 102(e) Date Feb. 26, 1998 PCT Filed Apr. 2, 1996 PCT Pub. No. WO97/36626 PCT Pub. Date Oct. 9, 1997The invention relates to an injection device for injecting a selectable dose of a liquid substance from an ampoule, located in an ampoule holder, comprising a piston and a sleeve-shaped mechanism holder, in the interior of which a longitudinally shiftable shaft is provided, the shaft being surrounded by an also longitudinally shiftable advancing sleeve coupled thereto. For selecting a dose of the liquid substance to be injected, a dosing sleeve with a stepped member is provided, the dose to be respectively administered being adjustable by a rotation of the dosing sleeve with the stepped member. The adjusted dose is readable via a dose imprint on the dosing sleeve. The actually possibly administrable dose can be read on a dose scale, fastened to the advancing sleeve, by means of the cooperation of a stop, fastened to the lower end area of the advancing sleeve, with a partition member, fastened to the shaft, the advancing sleeve being, as a result of this mechanism, then no longer movable if the supply of the ampoule is completely used up.
Patent JP-4311765-B2 (JP)
IPC: A61K31/4738
Filed: 1998-02-11
Granted: 2009-08-12
Abstract: This invention relates to novel derivatives of camptothecin, and will, particularly to derivatives having a substitution at the C-7 position, or at one of the C-9, C-10, C-11 or C-12 positions, or to disubstituted derivatives having a first substitution at C-7 and a second at one of C-9, C-10, C-11 or C-12. The invention also includes methods of using the compounds as Topoisomerase I inhibitors to treat patients with cancer. The invention also includes pharmaceutical formulations which consist of the novel compounds in solution or suspension with one or more pharmaceutical excipients or diluents.
Patent JP-4215822-B2 (JP)
IPC: C40B50/14
Filed: 1997-04-24
Granted: 2009-01-28
Abstract: The present invention relates to the field of compounds which are substrates or inhibitors of proteolytic enzymes and to apparatus and methods for identifying substrates or inhibitors for proteolytic enzymes. We have devised a combinatorial method for the rapid indentification of binding motifs which will greatly expedite the synthesis of inhibitors of a variety of proteolytic enzymes such as aspartyl proteases, serine proteases, metallo proteases and cysteinyl proteases.
Patent ES-2254011-B2 (ES)
Title: Procedimiento de obtencion de materiales aglomerados con resinas para su empleo en construccion.
Inventor: PEREIRO LOPEZ GABRIEL
IPC: C08J5/02
Filed: 2004-10-06
Granted: 2007-02-01
Abstract: Procedimiento de obtención de materiales aglomerados a partir de conchas de moluscos con resinas fenólicas o de vermiculitas expandidas con resinas ureicas, para su uso en construcción. Inicialmente, se acondiciona la fase dispersa a emplear en cada caso; luego se adiciona el aglomerante, se mezclan ambos componentes hasta completa homogeneización, se acondiciona el molde, se prensa la mezcla, se desmolda y se procesa térmicamente, obteniéndose tableros o paneles de diversos tamaños y formas geométricas. Son de aplicación como aislantes, revestimientos, absorbentes acústicos, soluciones constructivas, elementos decorativos y soportes.
Patent ES-2282013-B2 (ES)
Title: Maquina abonadora centrifuga con doble disco.
Inventor: BRUN PLA PEDRO JOSE
IPC: A01C17/00
Filed: 2005-06-07
Granted: 2008-05-01
Abstract: Desde una tolva única el abono descarga por gravedad sobre un cono dosificador (8) en el que se establecen dos sectores superpuestos (8-8¿), con respectivas ventanas laterales (9-9¿) dotadas de trampillas de cierre (20) de manera que cada sector (8-8¿) permite la salida del abono hacia un disco dispersador, quedando los dos discos dispersadores (10) y (11) superpuestos e interacoplados coaxialmente, girando en sentidos contrarios y con alabes (19) inclinados también en sentidos contrarios, a la vez que un desatascador (18) alojado en el interior del cono dosificador (8) asegura la salida del abono por las ventanas (9-9¿). Se consigue de esta manera un reparto más homogéneo del abono y un óptimo rendimiento de la máquina.
Patent ES-2325049-B2 (ES)
Title: Deteccion y cuantificacion de iminas ciclicas basada en la union competitiva a receptores nicotinicos de acetilcolina.
Inventor: BOTANA LOPEZ LUIS MIGUEL
IPC: C07C251/02
Filed: 2008-02-21
Granted: 2010-03-16
Abstract: Detección y cuantificación de iminas cíclicas
basada en la unión competitiva a receptores nicotínicos de
acetilcolina. 
     Procedimiento de cuantificación de iminas
cíclicas basado en la unión competitiva  a receptores nicotínicos de
acetilcolina. Las iminas cíclicas gymnodiminas  y espirólidos pueden
aparecer como contaminantes en moluscos marinos destinados  al
consumo humano. Se ha utilizado la capacidad de estas iminas
cíclicas  de unirse a los receptores nicotínicos de acetilcolina de
forma competitiva  con la a-bungarotoxina para
desarrollar un método de detección de  estas  toxinas en solución.
La invención se basa en la cuantificación de la unión  de los
receptores nicotínicos a la a-bungarotoxina
utilizando técnicas  que detectan interacciones moleculares, como la
medición de los cambios  de polarización de fluorescencia o la
monitorización de cambios del índice  de refracción en las
proximidades de una superficie. Esta señal de unión  de
a-bungarotoxina al receptor se inhibe por la
presencia de iminas cíclicas  en solución permitiendo la
cuantificación de estas toxinas marinas mediante  una calibración
previa.
Patent ES-2391112-B2 (ES)
Title: Sistema de proyeccion espacial de realidad aumentada fijado a la cabeza
Inventor: DOMINGUEZ CABRERIZO SERGIO
IPC: G02B27/01
Filed: 2010-07-16
Granted: 2013-04-11
Abstract: El sistema objeto de la invención es un dispositivo de proyección de realidad aumentada fijado a la cabeza, de tal forma que los movimientos que realice ésta son seguidos de forma solidaria. Además del sistema de fijación consta de una cámara de video que registra información del entorno, y de un proyector mediante el que se superpone información generada por un computador sobre él. Al ser solidario con el movimiento de la cabeza, se conoce la posición relativa entre sistema y usuario, lo que permite que los elementos proyectados mantengan la coherencia espacial con el entorno desde su punto de vista, de tal forma que la proyección puede simular objetos 3D situados en dicho entorno, mediante la variación de la proyección de acuerdo con los movimientos registrados; de esta forma, si el observador se desplaza en el entorno la proyección variará en correspondencia para simular la presencia de objetos estáticos.